|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.97 EUR | -1.98% |
|
-1.00% | -20.59% |
| Apr. 25 | Heidelberg Pharma AG Reports Earnings Results for the First Quarter Ended February 29, 2024 | CI |
| Apr. 23 | Transcript : Heidelberg Pharma AG - Special Call |
Heidelberg Pharma AG reported earnings results for the full year ended November 30, 2023. For the full year, the company reported sales was EUR 9.86 million compared to EUR 18.51 million a year ago. Revenue was EUR 16.8 million compared to EUR 19.86 million a year ago.
Net loss was EUR 20.35 million compared to EUR 19.7 million a year ago. Basic loss per share from continuing operations was EUR 0.44 compared to EUR 0.53 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -20.59% | 148M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
HEIDELBERG PHARMA AG 
